Vivek Jha
@vjha.bsky.social
Pinned
Vivek Jha
@vjha.bsky.social
· Jan 4
2024 – A Year in Review - Indian Journal of Nephrology
[article]
indianjnephrol.org
Good noon all,
IJN: Year: 2025, Volume: 35, Issue: 1, January-February Issue of Indian Journal of Nephrology is live.
Kindly follow the link: indianjnephrol.org/current-issue/
@arvindcanchi.bsky.social @priti899.bsky.social
IJN: Year: 2025, Volume: 35, Issue: 1, January-February Issue of Indian Journal of Nephrology is live.
Kindly follow the link: indianjnephrol.org/current-issue/
@arvindcanchi.bsky.social @priti899.bsky.social
Reposted by Vivek Jha
Our Nutrition team took India’s voices to the global stage at 23rd IUNS International Congress of Nutrition in Paris. With 7 presentations, they showcased Indigenous food systems, dietary diversity, child feeding practices, food procurement, Indian adaptation of the Mediterranean diet & more. [1/2]
August 29, 2025 at 8:14 AM
Our Nutrition team took India’s voices to the global stage at 23rd IUNS International Congress of Nutrition in Paris. With 7 presentations, they showcased Indigenous food systems, dietary diversity, child feeding practices, food procurement, Indian adaptation of the Mediterranean diet & more. [1/2]
Reposted by Vivek Jha
🏅 Prof. Vivekanand Jha @vjha.bsky.social (India), winner of the Jean Hamburger Award lite.spr.ly/6000KvmY
August 26, 2025 at 1:23 PM
🏅 Prof. Vivekanand Jha @vjha.bsky.social (India), winner of the Jean Hamburger Award lite.spr.ly/6000KvmY
First randomization in India for EASi-KIDNEY!🎉🥳
Big thanks to and the PGIMER team for leading the start, and to all our partner sites for their commitment and support.
Also to the fantastic colleagues at @georgeinstitute.bsky.social and Oxford NDPH
www.easikidney.org
Big thanks to and the PGIMER team for leading the start, and to all our partner sites for their commitment and support.
Also to the fantastic colleagues at @georgeinstitute.bsky.social and Oxford NDPH
www.easikidney.org
Welcome
EASi-KIDNEY is an international, multi-centre, randomised double-blind placebo-controlled trial to assess whether in addition to standard care, the drug vicadrostat reduces the risk of kidney disease ...
www.easikidney.org
August 23, 2025 at 2:42 AM
First randomization in India for EASi-KIDNEY!🎉🥳
Big thanks to and the PGIMER team for leading the start, and to all our partner sites for their commitment and support.
Also to the fantastic colleagues at @georgeinstitute.bsky.social and Oxford NDPH
www.easikidney.org
Big thanks to and the PGIMER team for leading the start, and to all our partner sites for their commitment and support.
Also to the fantastic colleagues at @georgeinstitute.bsky.social and Oxford NDPH
www.easikidney.org
New study: NOACs like apixaban safe & effective for short-term prevention of blood clots in primary membranous nephropathy patients with low albumin—no VTEs, low bleeding risk. Promising alternative to warfarin! #Nephrology #VTE #PatientCare t.co/mSt3nhKMvm @isn-india.bsky.social
https://indianjnephrol.org/apixaban-in-primary-membranous-nephropathy-report-from-the-itangible-registry/
t.co
June 27, 2025 at 3:25 PM
New study: NOACs like apixaban safe & effective for short-term prevention of blood clots in primary membranous nephropathy patients with low albumin—no VTEs, low bleeding risk. Promising alternative to warfarin! #Nephrology #VTE #PatientCare t.co/mSt3nhKMvm @isn-india.bsky.social
Listen to Dr Vasistha Tatapudi of from focusing on the use of pig kidneys in humans - the rationale, immunological challenges, and genetic modifications involved in overcoming hyperacute rejection. t.co/Htzs11a711
https://youtu.be/pbumiUjck1I?si=CShZCu48Gw3Ws84Z
t.co
June 27, 2025 at 2:32 PM
Listen to Dr Vasistha Tatapudi of from focusing on the use of pig kidneys in humans - the rationale, immunological challenges, and genetic modifications involved in overcoming hyperacute rejection. t.co/Htzs11a711
Nice case and good discussion on how to interpret clinical clues
Case Presentations in Nephrology - An Indian Society of Nephrology Initiative
YouTube Recording 👉 m.youtube.com/watch?v=0yuO...
Topic: Case of Anasarca
Moderator: Prof Vivekanand Jha, Chandigarh @vjha.bsky.social
Presented by - Dr Jugal Mehta (Mumbai)
YouTube Recording 👉 m.youtube.com/watch?v=0yuO...
Topic: Case of Anasarca
Moderator: Prof Vivekanand Jha, Chandigarh @vjha.bsky.social
Presented by - Dr Jugal Mehta (Mumbai)
June 27, 2025 at 12:25 AM
Nice case and good discussion on how to interpret clinical clues
Reposted by Vivek Jha
Case Presentations in Nephrology - An Indian Society of Nephrology Initiative
YouTube Recording 👉 m.youtube.com/watch?v=0yuO...
Topic: Case of Anasarca
Moderator: Prof Vivekanand Jha, Chandigarh @vjha.bsky.social
Presented by - Dr Jugal Mehta (Mumbai)
YouTube Recording 👉 m.youtube.com/watch?v=0yuO...
Topic: Case of Anasarca
Moderator: Prof Vivekanand Jha, Chandigarh @vjha.bsky.social
Presented by - Dr Jugal Mehta (Mumbai)
June 25, 2025 at 11:32 AM
Case Presentations in Nephrology - An Indian Society of Nephrology Initiative
YouTube Recording 👉 m.youtube.com/watch?v=0yuO...
Topic: Case of Anasarca
Moderator: Prof Vivekanand Jha, Chandigarh @vjha.bsky.social
Presented by - Dr Jugal Mehta (Mumbai)
YouTube Recording 👉 m.youtube.com/watch?v=0yuO...
Topic: Case of Anasarca
Moderator: Prof Vivekanand Jha, Chandigarh @vjha.bsky.social
Presented by - Dr Jugal Mehta (Mumbai)
Reposted by Vivek Jha
Effect of cholecalciferol on immune and vascular function in non-diabetic chronic kidney disease
frontiersin.org/journals/imm...
@vjha.bsky.social
frontiersin.org/journals/imm...
@vjha.bsky.social
Frontiers | Effect of cholecalciferol on immune and vascular function in non-diabetic chronic kidney disease
frontiersin.org
April 24, 2025 at 6:00 AM
Effect of cholecalciferol on immune and vascular function in non-diabetic chronic kidney disease
frontiersin.org/journals/imm...
@vjha.bsky.social
frontiersin.org/journals/imm...
@vjha.bsky.social
Reposted by Vivek Jha
Congratulations to Dr Jha and the team! Collaboration and data sharing is the way forward! 🇮🇳🏖️
Presenting #iTANGIBLE - a nationwide Indian collaborative effort to study common primary glomerular diseases in India.
➡️ The first such cohort in the developing (majority) world
➡️ Will help understand disease phenotypes in the Indian context
Funded by #ICMR
www.kireports.org/article/S246...
➡️ The first such cohort in the developing (majority) world
➡️ Will help understand disease phenotypes in the Indian context
Funded by #ICMR
www.kireports.org/article/S246...
Decoding Glomerular Disease: Baseline Profiles and Insights From the I-TANGIBLE Registry
Glomerular diseases are a leading cause of kidney disease worldwide, especially in
low-and middle-income countries. At the global level, collaborative initiatives have
been started to provide informat...
www.kireports.org
March 21, 2025 at 11:18 PM
Congratulations to Dr Jha and the team! Collaboration and data sharing is the way forward! 🇮🇳🏖️
Presenting #iTANGIBLE - a nationwide Indian collaborative effort to study common primary glomerular diseases in India.
➡️ The first such cohort in the developing (majority) world
➡️ Will help understand disease phenotypes in the Indian context
Funded by #ICMR
www.kireports.org/article/S246...
➡️ The first such cohort in the developing (majority) world
➡️ Will help understand disease phenotypes in the Indian context
Funded by #ICMR
www.kireports.org/article/S246...
Decoding Glomerular Disease: Baseline Profiles and Insights From the I-TANGIBLE Registry
Glomerular diseases are a leading cause of kidney disease worldwide, especially in
low-and middle-income countries. At the global level, collaborative initiatives have
been started to provide informat...
www.kireports.org
March 20, 2025 at 2:36 AM
Presenting #iTANGIBLE - a nationwide Indian collaborative effort to study common primary glomerular diseases in India.
➡️ The first such cohort in the developing (majority) world
➡️ Will help understand disease phenotypes in the Indian context
Funded by #ICMR
www.kireports.org/article/S246...
➡️ The first such cohort in the developing (majority) world
➡️ Will help understand disease phenotypes in the Indian context
Funded by #ICMR
www.kireports.org/article/S246...
Reposted by Vivek Jha
Happy 20th anniversary #WorldKidneyDay 🎉
Two decades of successful awareness campaigns!
On this year, WKD invites you to ask yourself #AreYourKidneysOK? Knowing the answer to this question can detect signs of early kidney disease and prevent it from worsening.
Two decades of successful awareness campaigns!
On this year, WKD invites you to ask yourself #AreYourKidneysOK? Knowing the answer to this question can detect signs of early kidney disease and prevent it from worsening.
March 13, 2025 at 9:42 AM
Happy 20th anniversary #WorldKidneyDay 🎉
Two decades of successful awareness campaigns!
On this year, WKD invites you to ask yourself #AreYourKidneysOK? Knowing the answer to this question can detect signs of early kidney disease and prevent it from worsening.
Two decades of successful awareness campaigns!
On this year, WKD invites you to ask yourself #AreYourKidneysOK? Knowing the answer to this question can detect signs of early kidney disease and prevent it from worsening.
Remembering Bill Couser who we lost recently on this #WKD for his huge contributions to conceiving this initiative that has made such a difference to kidney health awareness around the world @theisn.org
www.kidney-international.org/article/S008...
www.kidney-international.org/article/S008...
March 13, 2025 at 12:03 PM
Remembering Bill Couser who we lost recently on this #WKD for his huge contributions to conceiving this initiative that has made such a difference to kidney health awareness around the world @theisn.org
www.kidney-international.org/article/S008...
www.kidney-international.org/article/S008...
Reposted by Vivek Jha
🌎Are your kidneys OK? ¿Tus riñones están bien? Vos reins vont bien? هل كليتيك بخير؟ ; आपकी किडनी ठीक है? Os seus rins estão bem? @theisn.org @drpriyajohn.bsky.social @nephromythri.bsky.social @sabinekaram.bsky.social
#WorldKidneyDay #KidneyHealthForAll #NephSky #BlueSky
#WorldKidneyDay #KidneyHealthForAll #NephSky #BlueSky
March 13, 2025 at 3:35 AM
🌎Are your kidneys OK? ¿Tus riñones están bien? Vos reins vont bien? هل كليتيك بخير؟ ; आपकी किडनी ठीक है? Os seus rins estão bem? @theisn.org @drpriyajohn.bsky.social @nephromythri.bsky.social @sabinekaram.bsky.social
#WorldKidneyDay #KidneyHealthForAll #NephSky #BlueSky
#WorldKidneyDay #KidneyHealthForAll #NephSky #BlueSky
Reposted by Vivek Jha
#WorldKidneyDay Rally in #Bangladesh.
March 13, 2025 at 3:46 AM
#WorldKidneyDay Rally in #Bangladesh.
Reposted by Vivek Jha
Congratulations Vivek on the broad swathe of holistic science presented at WCN in New Delhi. It was an outstanding meeting!
@vjha.bsky.social @charumalik.bsky.social @asnkidney.bsky.social @uncdeptmedicine.bsky.social
@vjha.bsky.social @charumalik.bsky.social @asnkidney.bsky.social @uncdeptmedicine.bsky.social
February 17, 2025 at 7:42 PM
Congratulations Vivek on the broad swathe of holistic science presented at WCN in New Delhi. It was an outstanding meeting!
@vjha.bsky.social @charumalik.bsky.social @asnkidney.bsky.social @uncdeptmedicine.bsky.social
@vjha.bsky.social @charumalik.bsky.social @asnkidney.bsky.social @uncdeptmedicine.bsky.social
Reposted by Vivek Jha
@vjha.bsky.social welcoming the audience to India and #ISNWCN
February 6, 2025 at 11:55 AM
@vjha.bsky.social welcoming the audience to India and #ISNWCN
Reposted by Vivek Jha
"Decoding Glomerulonephritis: Baseline Profiles and Insights from the I-TANGIBLE Registry" by Kavita Yadav, @vjha.bsky.social et al.
🔗 Download the visual abstract by @sayalibthakare.bsky.social www.theisn.org/wcn/w... #ISNWCN
🔗 Download the visual abstract by @sayalibthakare.bsky.social www.theisn.org/wcn/w... #ISNWCN
February 7, 2025 at 1:01 PM
"Decoding Glomerulonephritis: Baseline Profiles and Insights from the I-TANGIBLE Registry" by Kavita Yadav, @vjha.bsky.social et al.
🔗 Download the visual abstract by @sayalibthakare.bsky.social www.theisn.org/wcn/w... #ISNWCN
🔗 Download the visual abstract by @sayalibthakare.bsky.social www.theisn.org/wcn/w... #ISNWCN
Reposted by Vivek Jha
First steps in efforts to characterise the burden of CKDu across different regions. Fantastic work led by Charlotte in collaboration with so many brilliant investigators from around the world.
If we understand where it is, maybe we can understand what it is.
with @vjha.bsky.social and others
If we understand where it is, maybe we can understand what it is.
with @vjha.bsky.social and others
International prevalence patterns of low eGFR in adults aged 18-60 without traditional risk factors from a population-based cross-sectional disadvantaged populations #eGFR epidemiology (DEGREE) study
doi.org/10.1016/j.kint.2024.11.028
#CKDu #CKDnt #chronickidneydisease #NephSky #MedSky
doi.org/10.1016/j.kint.2024.11.028
#CKDu #CKDnt #chronickidneydisease #NephSky #MedSky
January 16, 2025 at 12:00 PM
First steps in efforts to characterise the burden of CKDu across different regions. Fantastic work led by Charlotte in collaboration with so many brilliant investigators from around the world.
If we understand where it is, maybe we can understand what it is.
with @vjha.bsky.social and others
If we understand where it is, maybe we can understand what it is.
with @vjha.bsky.social and others
🌍 Dialysis in LMICs: A Lesson from Thailand
Thailand’s PD-first policy (2008-2022) transformed dialysis care, saving lives and reducing poverty. But a 2022 shift to patient choice revealed unintended consequences. Lessons for universal health coverage worldwide. #UHC #GlobalHealth
Thailand’s PD-first policy (2008-2022) transformed dialysis care, saving lives and reducing poverty. But a 2022 shift to patient choice revealed unintended consequences. Lessons for universal health coverage worldwide. #UHC #GlobalHealth
January 28, 2025 at 10:34 AM
🌍 Dialysis in LMICs: A Lesson from Thailand
Thailand’s PD-first policy (2008-2022) transformed dialysis care, saving lives and reducing poverty. But a 2022 shift to patient choice revealed unintended consequences. Lessons for universal health coverage worldwide. #UHC #GlobalHealth
Thailand’s PD-first policy (2008-2022) transformed dialysis care, saving lives and reducing poverty. But a 2022 shift to patient choice revealed unintended consequences. Lessons for universal health coverage worldwide. #UHC #GlobalHealth
Reposted by Vivek Jha
Good noon all,
IJN: Year: 2025, Volume: 35, Issue: 1, January-February Issue of Indian Journal of Nephrology is live.
Kindly follow the link: indianjnephrol.org/current-issue/
@arvindcanchi.bsky.social @priti899.bsky.social
IJN: Year: 2025, Volume: 35, Issue: 1, January-February Issue of Indian Journal of Nephrology is live.
Kindly follow the link: indianjnephrol.org/current-issue/
@arvindcanchi.bsky.social @priti899.bsky.social
2024 – A Year in Review - Indian Journal of Nephrology
[article]
indianjnephrol.org
January 4, 2025 at 11:37 AM
Good noon all,
IJN: Year: 2025, Volume: 35, Issue: 1, January-February Issue of Indian Journal of Nephrology is live.
Kindly follow the link: indianjnephrol.org/current-issue/
@arvindcanchi.bsky.social @priti899.bsky.social
IJN: Year: 2025, Volume: 35, Issue: 1, January-February Issue of Indian Journal of Nephrology is live.
Kindly follow the link: indianjnephrol.org/current-issue/
@arvindcanchi.bsky.social @priti899.bsky.social
Good noon all,
IJN: Year: 2025, Volume: 35, Issue: 1, January-February Issue of Indian Journal of Nephrology is live.
Kindly follow the link: indianjnephrol.org/current-issue/
@arvindcanchi.bsky.social @priti899.bsky.social
IJN: Year: 2025, Volume: 35, Issue: 1, January-February Issue of Indian Journal of Nephrology is live.
Kindly follow the link: indianjnephrol.org/current-issue/
@arvindcanchi.bsky.social @priti899.bsky.social
2024 – A Year in Review - Indian Journal of Nephrology
[article]
indianjnephrol.org
January 4, 2025 at 11:37 AM
Good noon all,
IJN: Year: 2025, Volume: 35, Issue: 1, January-February Issue of Indian Journal of Nephrology is live.
Kindly follow the link: indianjnephrol.org/current-issue/
@arvindcanchi.bsky.social @priti899.bsky.social
IJN: Year: 2025, Volume: 35, Issue: 1, January-February Issue of Indian Journal of Nephrology is live.
Kindly follow the link: indianjnephrol.org/current-issue/
@arvindcanchi.bsky.social @priti899.bsky.social
Reposted by Vivek Jha
The Limits of Generalizability: Pitfalls of Applying Western #GFR Estimation Models to Global Populations
doi.org/10.1016/j.ek...
Original Article: doi.org/10.1016/j.ek...
#KIRCommentary
doi.org/10.1016/j.ek...
Original Article: doi.org/10.1016/j.ek...
#KIRCommentary
December 31, 2024 at 3:00 PM
The Limits of Generalizability: Pitfalls of Applying Western #GFR Estimation Models to Global Populations
doi.org/10.1016/j.ek...
Original Article: doi.org/10.1016/j.ek...
#KIRCommentary
doi.org/10.1016/j.ek...
Original Article: doi.org/10.1016/j.ek...
#KIRCommentary
‘A letter by Richard Lambert, former editor of the Financial Times, gives a fascinating insight into how Manmohan Singh was not just about economic reforms, but reforms with a heart.’
From - The India Cable by @thewire.in
From - The India Cable by @thewire.in
January 1, 2025 at 3:37 AM
‘A letter by Richard Lambert, former editor of the Financial Times, gives a fascinating insight into how Manmohan Singh was not just about economic reforms, but reforms with a heart.’
From - The India Cable by @thewire.in
From - The India Cable by @thewire.in
Reposted by Vivek Jha
📖 Don't miss our KI #ISNFridaySelection: Transfusion-induced HLA sensitization in wait-list patients and kidney transplant recipients www.kidney-internati... #NephSky
December 20, 2024 at 6:00 AM
📖 Don't miss our KI #ISNFridaySelection: Transfusion-induced HLA sensitization in wait-list patients and kidney transplant recipients www.kidney-internati... #NephSky
Reposted by Vivek Jha
Excited to see the Global Kidney Patient Trials Network (GKPTN) featured in @jama.com! Endorsed by ISN, this initiative is transforming CKD research and improving access to innovative treatments worldwide. Learn more: jamanetwork.com/jour... #Nephsky @vjha.bsky.social
December 17, 2024 at 11:00 AM
Excited to see the Global Kidney Patient Trials Network (GKPTN) featured in @jama.com! Endorsed by ISN, this initiative is transforming CKD research and improving access to innovative treatments worldwide. Learn more: jamanetwork.com/jour... #Nephsky @vjha.bsky.social